
Linklaters has advised the global banking syndicate on a bond issuance by Novartis with an aggregate principal amount of US$5.5bn. The notes were issued by Novartis Capital Corporation and are guaranteed by Novartis AG and were registered with the U.S. Securities and Exchange Commission (SEC).
The international cross-practice Linklaters team was led by partner Marco Carbonare and senior U.S. counsel Kevin Roy, with Alexander Auster (Associate, all Corporate/M&A) as a core team member. Other team members included Omer Harel (Counsel, Tax), and the associates Alexander Gatlin, Marianna Troia (Corporate/M&A), Helena Obenheimer (Capital markets), and Young Jin Kim (Tax).
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record

